Alembic Pharmaceuticals Ltd.

View in App
546.00 -9.25 ▼-1.7%

26 May 2023, 04:01:00 PM
Volume: 5,606

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembicpharmaceuticals.com
Market Cap 10,743.16 Cr.
Enterprise Value(EV) 11,296.76 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 17.40 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 31.38 Trailing Twelve Months Ending 2023-03
Industry PE 31.87 Trailing Twelve Months Ending 2023-03
Book Value / Share 222.34 Trailing Twelve Months Ending 2023-03
Price to Book Value 2.46 Calculated using Price: 546.00
Dividend Yield 1.46 Period Ending 2022-03
No. of Shares Subscribed 19.66 Cr. 196,563,124 Shares
FaceValue 2
About Alembic Pharmaceuticals Ltd.
The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments.

Alembic Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Alembic Pharmaceuticals Ltd. Performance

View details >>
1 Day
-1.67%
1 Week
-1.06%
1 Month
-0.41%
3 Month
+2.82%
6 Month
-8.61%
1 Year
-26.08%
2 Year
-42.57%
5 Year
+28.46%
10 Year
+363.10%

Alembic Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 39.97 36.24 58.02 23.25 20.42 24.00 26.97 26.91 10.01
Return on Capital Employed (%) 43.54 37.54 65.86 28.87 22.15 22.66 23.30 26.28 11.16
Return on Assets (%) 18.79 18.76 33.75 14.97 12.25 13.15 14.64 17.22 7.27

Alembic Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 676 885 1,597 1,902 2,220 2,719 3,219 5,067 5,238 4,370
Non Curr. Liab. 94 72 84 94 576 570 1,047 361 162 52
Curr. Liab. 603 684 944 814 1,267 1,664 1,752 1,533 1,831 1,637
Minority Int. 0 0 -1 -29
Equity & Liab. 1,372 1,641 2,626 2,811 4,064 4,952 5,989 6,961 7,230 6,060
Non Curr. Assets 516 750 917 1,317 2,116 2,820 3,526 4,057 4,255 3,150
Curr. Assets 857 891 1,708 1,494 1,948 2,132 2,463 2,904 2,975 2,910
Misc. Exp. not W/O
Total Assets 1,372 1,641 2,626 2,811 4,064 4,952 5,989 6,961 7,230 6,060

Alembic Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 1,863 2,056 3,166 3,135 3,131 3,935 4,606 5,393 5,306 5,653
Other Income 4 12 9 3 35 27 14 87 50 3
Total Income 1,868 2,068 3,175 3,137 3,166 3,962 4,620 5,481 5,356 5,655
Total Expenditure -1,506 -1,661 -2,161 -2,520 -2,516 -3,079 -3,392 -3,913 -4,432 -4,944
PBIDT 362 407 1,014 617 650 883 1,228 1,568 925 711
Interest -10 -4 -5 -5 -3 -18 -27 -16 -18 -50
Depreciation -40 -44 -72 -83 -105 -115 -157 -183 -287 -275
Taxation -75 -76 -216 -122 -120 -157 -199 -253 -104 -13
Exceptional Items -44
PAT 236 283 720 407 421 593 801 1,115 516 373
Minority Interest 0 0 1 28
Share Associate 0 -4 -8 -9 0 32 5 -31
Other Related Items
Consolidated Net Profit 236 283 720 403 413 584 829 1,147 521 342
Adjusted EPS 12 15 38 21 22 31 44 58 27 17

Alembic Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 265 240 172 948 329 312 812 449 1,463 552
Cash Fr. Inv. -67 -81 -256 -307 -486 -884 -756 -732 -839 -372
Cash Fr. Finan. -229 -151 87 -224 -129 503 59 155 -597 -217
Net Change -31 8 3 417 -286 -69 115 -128 27 -37
Cash & Cash Eqvt 16 24 27 439 153 84 199 72 98 61

Alembic Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 69.48 69.48 69.48 69.48 69.61 69.61 69.61 69.61 69.61
Public 30.52 30.52 30.52 30.52 30.39 30.39 30.39 30.39 30.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Alembic Pharmaceuticals Ltd. Announcements

View details >>
Thu, 25 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February 2019 please find enclosed herewith the Annual Secretarial Compliance Report issued by M/s. Samdani Shah & Kabra Practicing Company Secretaries for the financial year ended 31st March 2023.
Wed, 24 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject please find enclosed herewith the intimation dated 24th May 2023 received from Link lntime India Private Limited Registrar and Share Transfer Agent regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022.
Tue, 23 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of advertisement related to notice of loss of share certificate(s) for claiming shares from IEPF Authority published by the Company on behalf of the registered shareholder in English language newspaper - Indian Express and Vernacular language (Gujarati) newspaper - Financial Express on 23rd May 2023.

Alembic Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 26 May 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low
RSI Trending Down RSI Trending Down
MFI Crossed 20 From Above MFI Crossed 20 From Above

Alembic Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Alembic Pharmaceuticals Ltd. FAQ's

What is Alembic Pharma share price?
Can I buy Alembic Pharma shares now?
What is the Dividend Yield of Alembic Pharma?
What is the Market Cap of Alembic Pharma?
What are the key metrics to analyse Alembic Pharma?
What is the 52 Week High and Low of Alembic Pharma?
What is the trend of Alembic Pharma share price?